Viewing data from:

TAZAROTENE

ANDA

TAZAROTENE | A213079 | PADAGIS ISRAEL PHARMACEUTICALS LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: TAZORAC(TE code: AB)

API Supply Chain3 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

ALIVUS LIFE SCIENCES LTDTAZAROTENE

DMF 214222008

PCASTAZAROTENE

DMF 251612011

OLON SPATAZAROTENE

DMF 296002015

CARDINAL HEALTH PTS LLCInactiveTAZAROTENE 1.5 MG AND 4.5 MG CAPSULES

DMF 168642003

BASF SEInactiveTAZAROTENE

DMF 190892006

WATSON PHARMA PRIVATE LTDInactiveTAZAROTENE

DMF 200632006

PIRAMAL HEALTHCARE CANADA LTDInactiveTAZAROTENE

DMF 248742011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 0.05%

0 patents0 exclusivities▴

GEL;TOPICAL | Approved: Apr 25, 2023

No patent or exclusivity listings for this strength.

#002 — 0.1%

0 patents0 exclusivities▾

GEL;TOPICAL | Approved: Apr 25, 2023